Estimated causal effects of common respiratory infections on cardiovascular risk: a meta-analysis

HM la Roi-Teeuw, M van Smeden, M Bos… - Open …, 2023 - openheart.bmj.com
Objective Literature supports associations between common respiratory tract infections
(RTIs) and risk of cardiovascular diseases, yet the importance of RTIs for cardiovascular risk …

A common framework for health data governance standards

F Torabi, E Squires, C Orton, S Heys, D Ford… - Nature Medicine, 2024 - nature.com
A common framework for health data governance standards | Nature Medicine Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

Neurovascular Adverse Effects of Sars-Cov-2 Vaccination

LD Panos, P Bargiotas, G Hadjigeorgiou… - Drug design …, 2024 - Taylor & Francis
The global deployment of SARS-CoV-2 vaccines has been pivotal in curbing the COVID-19
pandemic, reducing morbidity and mortality associated with the virus. While most of these …

Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the …

M Joy, U Agrawal, X Fan, C Robertson… - The Lancet Regional …, 2023 - thelancet.com
Background Thrombosis associated with thrombocytopenia was a matter of concern post
first and second doses of BNT162b2 and ChAdOx1 COVID-19 vaccines. Therefore, it is …

Stroke following coronavirus disease 2019 vaccination: evidence based on different designs of real-world studies

J Liu, F Cao, C Luo, Y Guo, J Yan - The Journal of Infectious …, 2023 - academic.oup.com
Background We aimed to evaluate whether coronavirus disease 2019 (COVID-19)
vaccination was associated with stroke. Methods We conducted a systematic meta-analysis …

Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine

D Yoon, HL Jeon, JH Kim, H Lee, JY Shin - JAMA Network Open, 2024 - jamanetwork.com
Importance Despite widespread immunization with the 23-valent pneumococcal
polysaccharide vaccine (PPSV23), safety concerns remain owing to a lack of statistical …

Risk of pulmonary embolism and deep vein thrombosis following COVID‐19: a nationwide cohort study

HJ Kim, S Jeong, J Song, SJ Park, YJ Park, YH Oh… - MedComm, 2024 - Wiley Online Library
Recent studies elucidate that coronavirus disease 2019 (COVID‐19) patients may face a
higher risk of cardiovascular complications. This study aimed to evaluate association of …

Deciphering changes in the incidence of hemorrhagic stroke and cerebral venous sinus thrombosis during the coronavirus disease 2019 pandemic: A nationwide time …

S Hyeon Cho, DK Kim, MC Song, E Lee, S Park… - PloS one, 2024 - journals.plos.org
Introduction Hemorrhagic stroke and cerebral venous sinus thrombosis (CVST) are
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case …

N Ab Rahman, TL King, KM Peariasamy, S Sivasampu… - Vaccine, 2024 - Elsevier
Objective To assess the potential risk of major adverse cerebro-cardiovascular events
(MACCE) associated with COVID-19 vaccination and SARS-CoV-2 infection. Methods This …

Incidence and individual risk prediction of post-COVID-19 cardiovascular disease in the general population: a multivariable prediction model development and …

HM la Roi-Teeuw, M van Smeden… - … heart journal open, 2023 - academic.oup.com
Aims Previous studies suggest relatively increased cardiovascular risk after COVID-19
infection. This study assessed incidence and explored individual risk and timing of …